首页> 外文期刊>Hepatitis Monthly >DIFFERENTIALLY EXPRESSED PROTEINS IN CHRONIC ACTIVE HEPATITIS, CIRRHOSIS, AND HCC RELATED TO HCV INFECTION IN COMPARISON WITH HBV INFECTION: A PROTEOMICS STUDY
【24h】

DIFFERENTIALLY EXPRESSED PROTEINS IN CHRONIC ACTIVE HEPATITIS, CIRRHOSIS, AND HCC RELATED TO HCV INFECTION IN COMPARISON WITH HBV INFECTION: A PROTEOMICS STUDY

机译:与HBV感染相比,与HCV感染相关的慢性活动性肝炎,肝硬化和HCC中差异表达的蛋白质:蛋白质组学研究

获取原文
           

摘要

Background: Hepatocellular carcinoma is a highly progressive cancer in the case of late diagnosis which is frequently associated with HBV and HCV viral infections.Objectives: To identify differentially expressed serum proteins among three main stages of HCV infection and healthy individuals, and their comparisons with sera from patients with the same stage of HBV infection.Patients and Methods: Two-dimensional polyacrylamide gel electrophoresis combined with liquid chromatography-tandem mass spectrometry was performed on 47 sera from healthy volunteers, those with chronic active hepatitis, cirrhosis and HCC patients associated with HBV and HCV infections.Results: Among these, 62 spots were differentially expressed ( 3 1.5 fold, P Conclusions: CD5L might be a useful biomarker for early diagnosis of HCC in HCV cirrhotic patients. LRG and HP a 2 isoforms could be potential markers for distinguishing viral HCC. Our results also further support the presence of varying molecules involved in hepatocarcinogenes is in HBV when compared with HCV infection.
机译:背景:肝细胞癌是一种晚期诊断的高度进展性癌症,通常与HBV和HCV病毒感染有关。目的:在HCV感染的三个主要阶段和健康个体中鉴定差异表达的血清蛋白,并将其与血清进行比较患者和方法:对健康志愿者,慢性活动性肝炎,肝硬化和HBV伴发肝癌患者的47例血清进行二维聚丙烯酰胺凝胶电泳与液相色谱-串联质谱联用。结果:其中62个点的差异表达(3 1.5倍,P结论):CD5L可能是早期诊断HCV肝硬化患者HCC的有用生物标志物,LRG和HP a 2亚型可能是区分HCV和HCV感染的潜在标志物。病毒性肝癌。我们的研究结果还进一步支持了涉及与HCV感染相比,HBV中含有肝致癌物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号